Exp Clin Endocrinol Diabetes 2018; 126(07): 465-466
DOI: 10.1055/s-0043-121266
Letter to the Editor
© Georg Thieme Verlag KG Stuttgart · New York

Comments to the Editor Concerning the Paper Entitled “Mitochondrial Dysfunction in Diabetic Cardiomyopathy: Effect of Mesenchymal Stem Cell with PPAR-γ Agonist or Exendin-4” Mohamed Abd Elaziz Wassef et al.

Alaaeldin Ahmed Hamza
1   Hormone Evaluation Department, National Organization for Drug Control and Research, Giza, Egypt
› Author Affiliations
Further Information

Publication History

received 07 September 2017
revised02 October 2017

accepted 06 October 2017

Publication Date:
08 November 2017 (online)